Skip to main content

Advertisement

SpringerLink
Log in

LUTS After Radiotherapy for Prostate Cancer: Evaluation and Treatment

  • Voiding Dysfunction Evaluation (C Gomez, Section Editor)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Use of radiotherapy including external beam radiation therapy (EBRT), brachytherapy (BT), and combination therapy (EBRT + BT) for the treatment of prostate cancer (PCa) is rising. Persistent lower urinary tract symptoms (LUTS) requiring surgical intervention after radiation for the treatment of prostate cancer are rare, and as a result, there is a paucity of data in the urologic literature. Owing to the location of the prostate, toxicity of radiotherapy for prostate cancer affects the bladder, prostate, urethra, and rectum which results in a range of complications including radiation cystitis, urinary incontinence, fistulas and outlet obstruction from bladder neck contractures, and the prostate or bulbomembranous urethral strictures. We review the cause and incidence of LUTS, workup and treatment options.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Howlader NA, Krapcho M, Garshell J, et al. SEER cancer statistics review, 1975–2010. Bethesda: National Cancer Institute; 2013.

    Google Scholar 

  2. Jani AB, Johnstone PAS, Liauw SL, et al. Prostate cancer modality time trend analyses from 1973 to 2004. A surveillance, epidemiology, and end results registry analysis. Am J Clin Oncol. 2010;33(2):168–72.

    PubMed  Google Scholar 

  3. Elliott SP, Meng MV, Elkin EP, et al. Incidence of urethral stricture after primary treatment for prostate cancer: data from CaPSURE. J Urol. 2001;1761–1765.

  4. Zili T, Taussky D, Donath D, et al. Urethra-sparing, intraoperative, real-time planned, permanent-seed prostate brachytherapy: toxicity analysis. Int J Radiat Oncol Biol Phys. 2011;81(4):e377–83.

    Article  Google Scholar 

  5. Keyes M, Miller S, Moravan V, et al. Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients. Int J Radiat Oncol Biol Phys. 2008;73(4):1023–32.

    Article  PubMed  Google Scholar 

  6. Hindson BR, Millar JL, Matheson B. Urethral strictures following high-dose-rate brachytherapy for prostate cancer: analysis of risk factors. J Brachy. 2012;03:004. Retrospective study that found that most urethral strictures after HDR brachytherapy occurred in the bulbomembranous urethra and that the dose schedule was the only significant predictor for increased stricture formation.

    Google Scholar 

  7. Sullivan L, Williams S, Tai KH, et al. Urethral stricture following high dose rate brachytherapy for prostate cancer. Radiother Oncol. 2009;91(2):232–6.

    Article  PubMed  Google Scholar 

  8. Zelefsky MJ, Hollister T, Raben A, et al. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys. 2000;47(5):1261–6.

    Article  CAS  PubMed  Google Scholar 

  9. Gelblum DY, Potters L, Ashley R, et al. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys. 1999;45(1):59–67.

    Article  CAS  PubMed  Google Scholar 

  10. Ghadjar P, Keller T, Rentsch C, et al. Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy. J Brachy. 2008;8(1):45–51.

    Article  Google Scholar 

  11. Heemsbergen WD, Al-Mamgani A, Witte MG, et al. Urinary obstruction in prostate cancer patients from the dutch trial (68 GY vs. 78 GY): relationships with local dose, acute effects, and baseline characteristics. J IJROBP. 2010;78(1):19–25.

    Google Scholar 

  12. Valakh V, Kirichenko A, Miller R, et al. Combination of IG-IMRT and permanent source prostate brachytherapy in patients with organ-confined prostate cancer: GU and GI toxicity and effect on erectile function. Brachytherapy. 2011;10(3):195–200.

    Article  PubMed  Google Scholar 

  13. Demanes DJ, Rodriguez RR, Schour L. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy’s 10-year results. Int J Radiat Oncol Biol Phys. 2005;61:1306–16.

    Article  PubMed  Google Scholar 

  14. Zelefsky MJ, Yamada Y, Pei X, et al. Comparison of tumor control and toxicity outcomes of high-dose intensity-modulated radiotherapy and brachytherapy for patients with favorable risk prostate cancer. J Urol. 2010;77(4):986–90.

    Article  Google Scholar 

  15. Fonteyne V, Geert V, Lumen N, et al. Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer. Radiother Oncol. 2009;92(1):42–7.

    Article  PubMed  Google Scholar 

  16. Mohammed N, Kestin L, Ghilezan M. Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2012;82(1):204–12.

    Article  PubMed  Google Scholar 

  17. Merrick G, Butler W, Tollenaar B, et al. The dosimetry of prostate brachytherapy induced urethral stricture. Int J Radiat Oncol Biol Phys. 2002;52:461–8.

    Article  PubMed  Google Scholar 

  18. Earley JJ, Abdelbaky AM, Cunningham MJ, et al. Correlation between prostate brachytherapy-related urethral stricture and peri-apical urethral dosimetry: a matched case-control study. Radiother Oncol. 2012;104:187–91. Matched case–control study demonstrating that higher radiation doses to the peri-apical and apical tissue are related to urethral stricture formation.

    Article  PubMed  Google Scholar 

  19. Hindson BR, Millar JL, Matheson B. Urethral strictures following high-dose rate brachytherapy for prostate cancer: analysis of risk factors. Brachytherapy. 2013;12:50–5.

    Article  PubMed  Google Scholar 

  20. Miller K, Poch M, Brandes SB. Urethral stricture and urethroplasty in the pelvic irradiated patient. In: Brandes MD, editor. Current clinic urology: urethral reconstructive surgery, vol. 241. Totowa: Humana Press; 2008. p. 241–9.

    Chapter  Google Scholar 

  21. Devisetty K, Zorn KC, Katz MH, et al. External beam radiation therapy after transurethral resection of the prostate: a report on acute and late genitourinary toxicity. Int J Radiat Oncol Biol Phys. 2010;77(4):1060–5.

    Article  PubMed  Google Scholar 

  22. Seymore CH, El-Mahdi AM, Schellhammer PF. The effect of prior transurethral resection of the prostate on post radiation urethral strictures and bladder neck contractures. Int J Radiat Oncol Biol Phys. 1986;12:1597–600.

    Article  CAS  PubMed  Google Scholar 

  23. Sandhu AS, Zelefsky MJ, Lee HJ, et al. Long-term urinary toxicity after 3D CRT for prostate cancer in patients with prior history of TURP. Int J Radiat Oncol Biol Phys. 2000;48:643–7.

    Article  CAS  PubMed  Google Scholar 

  24. Marks LB, Carroll PR, Dugan TC, et al. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys. 1995;31(5):1257–80.

    Article  CAS  PubMed  Google Scholar 

  25. Kim S, Moore D, Shih W, et al. Severe genitourinary toxicity following radiation therapy for prostate cancer—how long does it last? J Urol. 2013;189:116–21. SEER population cohort study that demonstrated that the increased risk of grade 2–4 genitourinary toxicities due to radiation for prostate cancer persists 10 years after treatment and thereafter.

    Article  PubMed  Google Scholar 

  26. Meeks JJ, Brandes SB, Morey AF, et al. Urethroplasty for radiotherapy induced bulbomembranous strictures: a multi-institutional experience. J Urol. 2011;185:1761–5.

    Article  PubMed  Google Scholar 

  27. Kuban DA, Tucker SL, Dong L, et al. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70(1):67–74.

    Article  PubMed  Google Scholar 

  28. Peters ST, Heemsbergen WD, van Putten WL, et al. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys. 2005;61(4):1019–34.

    Article  Google Scholar 

  29. Shakespeare D, Mitchell DM, Carey BM, et al. Recto-urethral fistula following brachytherapy for localized prostate cancer. Color Dis. 2006;9:328–31.

    Article  Google Scholar 

  30. Theodorescu D, Gillenwater JY, Koutrouvelis PG. Prostatourethral-rectal fistula after prostate brachytherapy. Cancer. 2000;89(10):2085–91.

    Article  CAS  PubMed  Google Scholar 

  31. Demanes DJ, Rodriguez RR, Schour L, et al. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy’s 10-year results. Int J Radiat Oncol Biol Phys. 2005;61(5):1306–16.

    Article  PubMed  Google Scholar 

  32. Nam RK, Cheung P, Herschorn S, et al. Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study. Lancet Oncol. 2014;15:223–31.

    Article  PubMed  Google Scholar 

  33. Zaorsky NG, Doyle LA, Yamoah K, et al. High dose rate brachytherapy boot for prostate cancer: a systematic review. Cancer Treat Rev. 2014;40(3):414–25.

    Article  PubMed  Google Scholar 

  34. Choudhura A, Arthur C, Malik J, et al. Patient-reported outcomes and health-related quality of life in prostate cancer treated with a single fraction of high dose rate brachytherapy combined with hypofractionated external beam radiotherapy. Clin Oncol. 2014;26(10):661–7.

    Article  Google Scholar 

  35. Badaus L, Bolla M, Bossi A, et al. Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature. Eur Urol. 2012;61(1):112–27.

    Article  Google Scholar 

  36. Faris SF, Milam DF, Dmochowski RR, et al. Urinary diversions after radiation for prostate cancer: indications and treatment. Urology. 2014;84(3):702–6.

    Article  PubMed  Google Scholar 

  37. Hechenbleikner EM, Buckley JC, Wick EC. Acquired rectourethral fistulas in adults: a systematic review of surgical repair techniques and outcomes. Dis Colon Rectum. 2013;56:374–83. Systematic review of studies reporting on surgical repairs of acquired rectourethral fistulas in adults which found that the percentage of acquired rectourethral fistula due to radiation is increasing over time and that rectourinary fistulas in irradiated patients are more likely to require permanent urinary diversion compared to nonirradiated patients (42.5 vs 4 %). Recommend avoiding rectal biopsy in patients with a history of radiation because this is a risk factor for fistula formation. Also recommend muscle interposition for irradiated cases.

    Article  PubMed  Google Scholar 

  38. Marguet C, Raj GV, Brashears JH, et al. Rectourethral fistula after combination radiotherapy for prostate cancer. Urology. 2007;69:898–901.

    Article  PubMed  Google Scholar 

  39. Matsushita K, Ginsburg L, Mian BM, et al. Pubovesical fistula: a rare complication after treatment of prostate cancer. J Urol. 2012;80(2):446–51.

    Article  Google Scholar 

  40. Hofer MD, Zhao LC, Morey AF, et al. Outcomes after urethroplasty for radiotherapy induced bulbomembranous urethral stricture disease. J Urol. 2013;191:1307–12. Multi-institution retrospective study that demonstrated that radiation induced strictures can be managed with EPA with success rates of 69.7 %.

    Article  PubMed  Google Scholar 

  41. Elliott SP, McAninch JW, Chi T, et al. Management of severe urethral complications of prostate cancer therapy. J Urol. 2006;176:2508–13.

    Article  PubMed  Google Scholar 

  42. Glass AS, McAninch JW, Zaid UB, et al. Urethroplasty after radiation therapy for prostate cancer. Urology. 2012;79(6):1402–5.

    Article  PubMed Central  PubMed  Google Scholar 

  43. Culty T, Boccon-Gibod L. Anastomotic urethroplasty for posttraumatic urethral stricture: previous urethral manipulation has a negative impact on the final outcome. J Urol. 2007;177:1374–7.

    Article  PubMed  Google Scholar 

  44. Martinez-Peneiro JA, Carcamo P, Garcia Matres MJ, et al. Excision and anastomotic repair for urethral stricture disease: experience with 150 cases. Eur Urol. 1997;32(4):433–41.

    Google Scholar 

  45. Breyer BN, McAninch JW, Whitson JM, et al. Multivariate analysis of risk factors for long-term urethroplasty outcome. J Urol. 2010;183:613–7.

    Article  PubMed  Google Scholar 

  46. Anger JT, Raj GV, Delvecchio FC, et al. Anastomotic contracture and incontinence after radical prostatectomy: a graded approach to management. J Urol. 2005;173:1143–6.

    Article  PubMed  Google Scholar 

  47. Anger J. Management of recalcitrant bladder neck contracture after radical prostatectomy for prostate cancer. UroLume® stent. J Urol. 2011;185(2):391–2.

    Article  PubMed  Google Scholar 

  48. Erickson BA, McAninch JW, Eisenberg ML, et al. Management for prostate cancer treatment related posterior urethral and bladder neck stenosis with stents. J Urol. 2011;185:198–203.

    Article  PubMed Central  PubMed  Google Scholar 

  49. Elliott DS, Boone TB. Combined stent and artificial urinary sphincter for management of severe recurent bladder neck contracture and stress incontinence after prostatectomy: a long-term evaluation. J Urol. 2001;165(2):413–5.

    Article  CAS  PubMed  Google Scholar 

  50. Moreira Jr SG, Seigne JD, Ordorica RC, et al. Devastating complications after brachytherapy in the treatment of prostate adenocarcinoma. BJU Int. 2004;93(1):31–5.

    Article  PubMed  Google Scholar 

  51. Mundy AR, Andrich DE. Posterior urethral complications of the treatment of prostate cancer. BJU Int. 2012;110(3):304–25.

    Article  PubMed  Google Scholar 

  52. Herschorn S, Elliott S, Coburn M, et al. SIU/ICUD consultation on urethral strictures: posterior urethral stenosis after treatment of prostate cancer. Urology. 2014(83):S59–70. Comprehensive review, guidelines and algorithms regarding the management of posterior urethral strictures after treatment of prostate cancer.

  53. Torrey R, Rajeshuni N, Ruel N, et al. Radiation history affects continence outcomes after AdVance transobturator sling placement in patients with post-prostatectomy incontinence. Urology. 2013;82(3):713–7.

    Article  PubMed  Google Scholar 

  54. Mourtzinos A, Smith JJ, Barrett DM. Treatments for male urinary incontinence: a review. AUA Updat Ser. 2005;24(15):121–31.

    Google Scholar 

  55. Brant WO, Erickson BA, Elliott SP, et al. Risk factors for erosion of artificial urinary sphincters: a multicenter prospective study. Urology. 2014;84(4):934–8. Multi-institutional prospective outcomes analysis of AUS placement that found that explantation rates were higher in patients with prior radiation, UroLume, AUS infection or erosion or 3.5 cm cuff placement.

    Article  PubMed Central  PubMed  Google Scholar 

  56. McGeady JB, McAninch JW, Truesdale MD, et al. Artificial urinary sphincter placement in compromised urethras and survival: a comparison of virgin, radiated and reoperative cases. J Urol. 2014;192:1756–61.

    Article  PubMed  Google Scholar 

  57. Simhan J, Morey AF, Singla N, et al. 3.5 cm artificial urinary sphincter cuff erosion occurs predominantly in irradiated patients. J Urol. 2015;193:1–5.

    Article  Google Scholar 

  58. Lane BR, Stein DE, Remzi FH, et al. Management of radiotherapy induced rectourethral fistula. J Urol. 2006;175(4):1382–8.

    Article  PubMed  Google Scholar 

  59. Hanna JM, Turley R, Castleberry A, et al. Surgical management of complex rectourethral fistulas in irradiated and nonirradiated patients. Dis Colon Rectum. 2014;57:1105–12.

    Article  PubMed  Google Scholar 

  60. Beddy D, Poskus T, Umbreit E, et al. Impact of radiotherapy on surgical repair and outcome in patients with rectourethral fistula. Colorectal Dis. 2013;15(12):1515–20. Retrospective review of patients with rectourethral fistulas which found that patients with radiation-induced fistulas required permanent colostomy and urostomy compared to nonradiated patients. Also found that radiated patients typically underwent a transabdominal approach to fistula repair compared to nonradiated patients who typically had a perineal approach. Overall successful primary fistula repair was statistically more frequent in nonirradiated patients compared to radiated patients.

    Article  CAS  PubMed  Google Scholar 

  61. Voelzke BB, McAninch JW, Breyer BN, et al. Transperineal management for postoperative and radiation rectourethral fistulas. J Urol. 2013;189:966–71.

    Article  PubMed Central  PubMed  Google Scholar 

  62. Mundy AR, Andrich DE. Urorectal fistulae following the treatment of prostate cancer. BJU Int. 2010;107:1298–303.

    Article  PubMed  Google Scholar 

  63. Vanni AJ, Buckley JC, Zinman LN. Management of surgical and radiation induced rectourethral fistulas with an interposition muscle flap and selective buccal mucosal onlay graft. J Urol. 2010;194:2400–4.

    Article  Google Scholar 

  64. Linder BJ, Tarrell RF, Boorjian SA. Cystectomy for refractory hemorrhagic cystitis: contemporary etiology, presentation and outcomes. J Urol. 2014;192:1687–92.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

ᅟ

Conflict of Interest

Melissa Kaufman reports that she is a National Principal Investigator for Cook Myosite and a faculty member for a resident educational course for American Medical Systems.

Sarah Faris declares no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. GURS Reconstructive fellow, University of Iowa Hospital and Clinics, 200 Hawkins Dr, Iowa City, IA, 52242, USA

    Sarah Faris

  2. Vanderbilt University Medical Center, 1211 Medical Center Drive, Nashville, TN, 37232, USA

    Melissa Kaufman

Authors
  1. Sarah Faris
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Melissa Kaufman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Melissa Kaufman.

Additional information

This article is part of the Topical Collection on Voiding Dysfunction Evaluation

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Faris, S., Kaufman, M. LUTS After Radiotherapy for Prostate Cancer: Evaluation and Treatment. Curr Bladder Dysfunct Rep 10, 150–155 (2015). https://doi.org/10.1007/s11884-015-0292-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-015-0292-9

Keywords

Search

Navigation